Mammographic fibroglandular density, left breast
ICD-10 R92.322 is a billable code used to indicate a diagnosis of mammographic fibroglandular density, left breast.
Mammographic fibroglandular density refers to the composition of breast tissue as seen on a mammogram. It indicates the proportion of fibrous and glandular tissue compared to fatty tissue in the breast. High fibroglandular density can obscure the detection of breast cancer on mammograms, making it a significant factor in breast cancer screening. The left breast is specified in this code, indicating that the density is assessed specifically in that breast. Patients with high fibroglandular density may have an increased risk of breast cancer, necessitating closer monitoring and potentially additional imaging studies. This finding is often incidental, discovered during routine screening mammograms, and may not present with any symptoms. However, it is crucial for healthcare providers to communicate the implications of this finding to patients, including the need for regular follow-up and potential additional imaging, such as ultrasound or MRI, to ensure comprehensive breast health management.
Documentation should include a detailed history of breast health, any previous imaging results, and a discussion of the implications of fibroglandular density with the patient.
Patients presenting for routine screening who have a history of breast density issues or family history of breast cancer.
Internal medicine providers should ensure that patients understand the significance of their mammographic findings and the need for regular follow-up.
Acute care documentation should include any presenting symptoms, imaging results, and immediate management plans.
Patients presenting with breast pain or palpable masses who may have a history of high fibroglandular density.
Emergency providers should be aware of the implications of fibroglandular density when evaluating breast complaints, ensuring appropriate referrals for follow-up imaging.
Used during routine screening for breast cancer detection.
Documentation must include the reason for the mammogram and any findings.
Radiologists should ensure that findings related to fibroglandular density are clearly documented.
High fibroglandular density means that your breast tissue has a higher proportion of fibrous and glandular tissue compared to fatty tissue. This can make it harder to detect breast cancer on mammograms, so additional imaging may be recommended.
